Cargando…
A Second Leukotriene B(4) Receptor, Blt2: A New Therapeutic Target in Inflammation and Immunological Disorders
Leukotriene B(4) (LTB(4)) is a potent chemoattractant and activator of both granulocytes and macrophages. The actions of LTB(4) appear to be mediated by a specific G protein–coupled receptor (GPCR) BLT1, originally termed BLT (Yokomizo, T., T. Izumi, K. Chang, Y. Takuwa, and T. Shimizu. 1997. Nature...
Autores principales: | Yokomizo, Takehiko, Kato, Kazuhiko, Terawaki, Kan, Izumi, Takashi, Shimizu, Takao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193217/ https://www.ncbi.nlm.nih.gov/pubmed/10934230 |
Ejemplares similares
-
The leukotriene B(4) receptor BLT1 is stabilized by transmembrane helix capping mutations
por: Hori, Tetsuya, et al.
Publicado: (2015) -
Cell-Specific Transcriptional Regulation of Human Leukotriene B(4) Receptor Gene
por: Kato, Kazuhiko, et al.
Publicado: (2000) -
The absence of the leukotriene B(4) receptor BLT1 attenuates peripheral inflammation and spinal nociceptive processing following intraplantar formalin injury
por: Asahara, Miho, et al.
Publicado: (2015) -
The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
por: Jo-Watanabe, Airi, et al.
Publicado: (2019) -
Biochemical Characterization of Three BLT Receptors in Zebrafish
por: Okuno, Toshiaki, et al.
Publicado: (2015)